{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:08:24Z","timestamp":1790190504237,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800195"],"award-info":[{"award-number":["81800195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009399","name":"Peking University Third Hospital","doi-asserted-by":"publisher","award":["BYSYZD2019026"],"award-info":[{"award-number":["BYSYZD2019026"]}],"id":[{"id":"10.13039\/501100009399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-NCJH202201-0049"],"award-info":[{"award-number":["Y-NCJH202201-0049"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Clinical Key Specialty Construction Program, P. R. China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06579-5","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T03:28:10Z","timestamp":1760066890000},"page":"5829-5840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A comprehensive analysis of B symptoms reveals prognosis and heterogeneity across different sites of diffuse large B-cell lymphoma"],"prefix":"10.1007","volume":"104","author":[{"given":"Chaoling","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyuan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zining","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"6579_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cancergen.2018.08.001","volume":"228\u2013229","author":"F Magnoli","year":"2018","unstructured":"Magnoli F et al (2018) Primary extranodal diffuse large B-cell lymphomas: many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases. Cancer Genet 228\u2013229:28\u201340","journal-title":"Cancer Genet"},{"issue":"5","key":"6579_CR2","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ajh.25460","volume":"94","author":"Y Liu","year":"2019","unstructured":"Liu Y, Barta SK (2019) Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment. Am J Hematol 94(5):604\u2013616","journal-title":"Am J Hematol"},{"issue":"16","key":"6579_CR3","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump M, Neelapu SS, Farooq U et al (2017) Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood 130(16):1800\u20131808","journal-title":"Blood"},{"issue":"1","key":"6579_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/bjh.15652","volume":"184","author":"B B\u00f6ll","year":"2019","unstructured":"B\u00f6ll B, G\u00f6rgen H (2019) The treatment of older Hodgkin lymphoma patients. Br J Haematol 184(1):82\u201392","journal-title":"Br J Haematol"},{"issue":"1","key":"6579_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/bjc.2014.277","volume":"111","author":"KT Troppan","year":"2014","unstructured":"Troppan KT, Schlick K, Deutsch A et al (2014) C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients. Br J Cancer 111(1):55\u201360","journal-title":"Br J Cancer"},{"issue":"10","key":"6579_CR6","doi-asserted-by":"publisher","first-page":"e10576","DOI":"10.15252\/emmm.201910576","volume":"11","author":"H Hashwah","year":"2019","unstructured":"Hashwah H, Bertram K, Stirm K et al (2019) The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma. EMBO Mol Med 11(10):e10576","journal-title":"EMBO Mol Med"},{"issue":"2","key":"6579_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/bjh.18208","volume":"198","author":"T Taniguchi","year":"2022","unstructured":"Taniguchi T, Nakayama S, Tanaka H et al (2022) Novel prognostic predictor of haemoglobin-platelet index in diffuse large B-cell lymphoma, not otherwise specified: anaemia and thrombocytopenia are associated with IL-6 production in lymphoma cells. Br J Haematol 198(2):360\u2013372","journal-title":"Br J Haematol"},{"issue":"2","key":"6579_CR8","first-page":"425","volume":"110","author":"X Guan","year":"2025","unstructured":"Guan X, Wang Y, Fang T et al (2025) Lymphoma cell-driven IL-16 is expressed in activated B-cell-like diffuse large B-cell lymphomas and regulates the pro-tumor microenvironment. Haematologica 110(2):425\u2013438","journal-title":"Haematologica"},{"issue":"8","key":"6579_CR9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00277-005-1020-x","volume":"84","author":"LM Pedersen","year":"2005","unstructured":"Pedersen LM et al (2005) Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin\u2019s lymphoma. Ann Hematol 84(8):510\u2013516","journal-title":"Ann Hematol"},{"issue":"1","key":"6579_CR10","first-page":"10","volume":"4","author":"B Vannata","year":"2015","unstructured":"Vannata B, Zucca E (2015) Primary extranodal B-cell lymphoma: current concepts and treatment strategies. Chin Clin Oncol 4(1):10","journal-title":"Chin Clin Oncol"},{"key":"6579_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/1471-2407-10-625","volume":"10","author":"R Griffiths","year":"2010","unstructured":"Griffiths R et al (2010) Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL). BMC Cancer 10:625","journal-title":"BMC Cancer"},{"issue":"21","key":"6579_CR12","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1200\/JCO.2017.72.7602","volume":"35","author":"C Grommes","year":"2017","unstructured":"Grommes C, DeAngelis LM (2017) Primary CNS lymphoma. J Clin Oncol 35(21):2410\u20132418","journal-title":"J Clin Oncol"},{"issue":"4","key":"6579_CR13","doi-asserted-by":"publisher","first-page":"100213","DOI":"10.1016\/j.esmoop.2021.100213","volume":"6","author":"T Calimeri","year":"2021","unstructured":"Calimeri T et al (2021) How we treat primary central nervous system lymphoma. ESMO Open 6(4):100213","journal-title":"ESMO Open"},{"issue":"4","key":"6579_CR14","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.21037\/tcr-20-3086","volume":"10","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) A visual model for prognostic estimation in patients with primary diffuse large B-cell lymphoma of small intestine and colon: analysis of 1,613 cases from the SEER database. Transl Cancer Res 10(4):1842\u20131855","journal-title":"Transl Cancer Res"},{"key":"6579_CR15","unstructured":"Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th Edition. New York:Springer, 2010. & Cheson BD, Fisher RI, Barrington SF, et al."},{"issue":"27","key":"6579_CR16","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068","journal-title":"J Clin Oncol"},{"issue":"1","key":"6579_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3109\/10428194.2012.710907","volume":"54","author":"M Mian","year":"2013","unstructured":"Mian M, Ferreri AJ, Rossi A et al (2013) Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer\u2019s ring in remission after anthracycline-containing chemotherapy. Leuk Lymphoma 54(1):62\u201368","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"6579_CR18","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00277-015-2358-3","volume":"94","author":"MW van der Poel","year":"2015","unstructured":"van der Poel MW, Mulder WJ, Ossenkoppele GJ et al (2015) Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study. Ann Hematol 94(8):1373\u20131379","journal-title":"Ann Hematol"},{"issue":"17","key":"6579_CR19","doi-asserted-by":"publisher","first-page":"18133","DOI":"10.1002\/cam4.6375","volume":"12","author":"M Salek","year":"2023","unstructured":"Salek M, Silverstein A, Tilly A et al (2023) Factors influencing treatment decision-making for cancer patients in low- and middle-income countries: a scoping review. Cancer Med 12(17):18133\u201318152","journal-title":"Cancer Med"},{"issue":"1","key":"6579_CR20","doi-asserted-by":"publisher","first-page":"100750","DOI":"10.1016\/j.esmoop.2022.100750","volume":"8","author":"T Melchardt","year":"2023","unstructured":"Melchardt T, Egle A, Greil R (2023) How i treat diffuse large B-cell lymphoma. ESMO Open 8(1):100750","journal-title":"ESMO Open"},{"issue":"11","key":"6579_CR21","doi-asserted-by":"publisher","first-page":"e865","DOI":"10.1016\/j.clml.2021.06.012","volume":"21","author":"Z Ahmed","year":"2021","unstructured":"Ahmed Z et al (2021) Primary mediastinal B-cell lymphoma: a 2021 update on genetics, diagnosis, and novel therapeutics. Clin Lymphoma Myeloma Leuk 21(11):e865\u2013e875","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"6579_CR22","doi-asserted-by":"publisher","first-page":"AB131","DOI":"10.1016\/j.jaad.2018.05.546","volume":"79","author":"F Ghazawi","year":"2018","unstructured":"Ghazawi F, Le M, Rahme E, Roshdy O, Popradi G, Glassman S, Sasseville D, Litvinov I (2018) Epidemiology of diffuse large B-cell lymphoma in Canada. J Am Acad Dermatol 79(3):AB131 (Supplement 1)","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"6579_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/neuonc\/nox187","volume":"20","author":"JS Mendez","year":"2018","unstructured":"Mendez JS et al (2018) The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades. Neuro Oncol 20(5):687\u2013694","journal-title":"Neuro Oncol"},{"issue":"13","key":"6579_CR24","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1080\/10428194.2019.1623886","volume":"60","author":"J Shaw","year":"2019","unstructured":"Shaw J et al (2019) Temporal trends in treatment and survival of older adult diffuse large B-cell lymphoma patients in the SEER-medicare linked database. Leuk Lymphoma 60(13):3235\u20133243","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"6579_CR25","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3109\/10428194.2014.940583","volume":"56","author":"BK Shah","year":"2015","unstructured":"Shah BK et al (2015) Disparities in receipt of radiotherapy and survival by age, sex and ethnicity among patients with stage I diffuse large B-cell lymphoma. Leuk Lymphoma 56(4):983\u2013986","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"6579_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12885-023-10548-4","volume":"23","author":"L Gao","year":"2023","unstructured":"Gao L, Chen X, Zhao J et al (2023) Advanced Ann Arbor stage and age over 60 years as prognostic predictors in patients with primary cervical lymphoma: a retrospective cohort study and systematic review. BMC Cancer 23(1):95","journal-title":"BMC Cancer"},{"issue":"5","key":"6579_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.clml.2023.01.015","volume":"23","author":"K MacDougall","year":"2023","unstructured":"MacDougall K et al (2023) Impact of race and age and their interaction on survival outcomes in patients with diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk 23(5):379\u2013384","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"6579_CR28","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3109\/10428191003793358","volume":"51","author":"A Mazloom","year":"2010","unstructured":"Mazloom A et al (2010) Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson cancer center experience. Leuk Lymphoma 51(7):1217\u20131224","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"6579_CR29","first-page":"291","volume":"16","author":"B Cao","year":"2011","unstructured":"Cao B et al (2011) A clinical analysis of primary testicular diffuse large B-cell lymphoma in China. Hematology (Amsterdam, Netherlands) 16(5):291\u2013297","journal-title":"Hematology (Amsterdam, Netherlands)"},{"issue":"1","key":"6579_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1200\/JCO.2003.11.141","volume":"21","author":"E Zucca","year":"2003","unstructured":"Zucca E et al (2003) Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group. J Clin Oncol: Off J Am Soc Clin Oncol 21(1):20\u201327","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"4","key":"6579_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.autrev.2010.09.026","volume":"10","author":"P Jacobo","year":"2011","unstructured":"Jacobo P, Guazzone VA, Theas MS, Lustig L (2011) Testicular autoimmunity. Autoimmun Rev 10(4):201\u2013204","journal-title":"Autoimmun Rev"},{"issue":"10","key":"6579_CR32","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/PAS.0000000000000923","volume":"41","author":"X Li","year":"2017","unstructured":"Li X et al (2017) Primary bone lymphoma exhibits a favorable prognosis and distinct gene expression signatures resembling diffuse large B-cell lymphoma derived from centrocytes in the germinal center. Am J Surg Pathol 41(10):1309\u20131321","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"6579_CR33","first-page":"1602","volume":"16","author":"H Shen","year":"2018","unstructured":"Shen H et al (2018) Primary extra-nodal diffuse large B-cell lymphoma: a prognostic analysis of 141 patients. Oncol Lett 16(2):1602\u20131614","journal-title":"Oncol Lett"},{"key":"6579_CR34","doi-asserted-by":"publisher","first-page":"784691","DOI":"10.3389\/fimmu.2021.784691","volume":"12","author":"E Dumontet","year":"2021","unstructured":"Dumontet E et al (2021) Bone marrow lymphoid niche adaptation to mature B cell neoplasms. Front Immunol 12:784691","journal-title":"Front Immunol"},{"issue":"25","key":"6579_CR35","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1182\/blood.2023020911","volume":"144","author":"M Roschewski","year":"2024","unstructured":"Roschewski M, Phelan JD, Jaffe ES (2024) Primary large B-cell lymphomas of immune-privileged sites. Blood 144(25):2593\u20132603 (Published online April 18, 2024)","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06579-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06579-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06579-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T02:30:46Z","timestamp":1764729046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06579-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6579"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06579-5","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"1 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the conduction of our study, we rigorously comply with the International Conference and the Declaration of Helsinki, also the Human Research Ethics Committee of Peking University Third Hospital approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have made their consent to participate into this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}